InfusionCapital CEO Featured Speaker
at Arnstein & Lehr Securities Conference
Fort Lauderdale, FL,
April 17, 2008 – InfusionCapital announced today that
CEO Kelly McCarthy will be a featured speaker at the
annual Florida Securities Conference held by Arnstein &
Lehr, LLP, one of the country’s oldest and most
respected law firms. Ms. McCarthy will address the key
role of investor relations and strategic public
relations in the many stages of the capitalization
process, as well as in the ongoing operations of all
types of publicly traded companies.
“It is a pleasure to be invited to speak
at this prestigious event,” stated Kelly McCarthy, CEO
of InfusionCapital. “We are extremely proud of
InfusionCapital’s expertise in Investor Relations and
look forward to sharing our process with all those in
attendance at the conference.
About Arnstein &
Lehr, LLP
Celebrating its 115th anniversary in 2008, Arnstein &
Lehr LLP has served clients, large and small, throughout
the United States and abroad. It is a full-service firm
with attorneys practicing in five main practice areas -
Business, Litigation, Local Government, Tax and Estate
Planning Services, and Real Estate. Arnstein & Lehr has
a diverse client base including large corporations
listed on the public stock exchanges, middle market
companies, non-profit organizations and emerging
businesses. Clients include governmental bodies,
healthcare entities, financial institutions, trade
associations, and a broad range of businesses in the
retail, industrial, manufacturing, distribution,
technology, and services sectors. The Firm also counsels
individuals as to their personal needs, including estate
planning, probate matters and the transfer of wealth and
business interests from one generation to another.
Arnstein & Lehr has offices in Illinois, Florida and
Wisconsin. For additional information about Arnstein &
Lehr, visit
www.arnstein.com.
About InfusionCapital
InfusionCapital is an investment banking consultancy
firm, specialized in a unique, integrated approach to
capital formation for small cap and emerging growth
companies. The firm has extensive experience in
assisting client companies with each phase of
capitalization and the complex processes that accompany
it.
They leverage their years of investment banking
experience on Wall Street, and their long-term
relationships with leading portfolio management firms,
key investment managers, and national brokerages to help
clients make the right connections and deliver a
consistently powerful message that gets results. For
further information about InfusionCapital, visit
www.infusioncapital.com.
For more
information, contact:
Andrew Zelman
Infusion Capital
407-566-1090
www.infusioncapital.com